Sanofi-aventis CFO Jerome Contamine announced plans for further restructuring in order to offset a reduction in revenue due to healthcare reforms in Europe, Bloomberg reported on Wednesday. "The way to cope with that is to continue to cut costs," the executive said, adding: "We are restructuring. We are changing our marketing model. We are merging sales forces, we are reducing sales forces, having a multiproduct sales force."
In keeping with CEO Chris Viehbacher's plans to look to emerging markets for new income to offset a reduction in sales due to increased competition from generic drugs, Contamine noted that the drugmaker may undertake "another group of bolt-on acquisitions" in emerging markets. He added that "emerging markets [are] a volume market. What is important is to have the right brand. We don’t see any squeeze so far on the overall margin. We need to sell more volume."
To read more Top Story articles, click here.